Risk Factors and Deep Learning Model for CI-AKI

N/AActive Not RecruitingNCT06596785

Xiao Li，MD2,000 enrolled

Overview

Contrast-associated acute kidney injury (CI-AKI) is a sudden and significant decline in renal function resulting from the use of a contrast agent.

Contrast-associated acute kidney injury (CI-AKI) is a sudden and significant decline in renal function resulting from the use of a contrast agent. Despite the frequent use of iodinated contrast agents in medical investigations, predictive models for CI-AKI are scarce. This study aimed to construct and validate interpretable deep learning models for the early risk prediction of acute kidney injury (AKI) associated with iodinated contrast agents.

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

AKI - Acute Kidney Injury

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * patients who received iodinated contrast agents during hospitalization * age ≥ 18 years * hospitalization length ≥ 48 hours * at least two serum creatinine tests during hospitalization Exclusion Criteria: * patients with stage 4 or 5 chronic kidney disease prior to admission * patients undergoing hemodialysis, hemofiltration or peritoneal before admission * a history of nephrectomy or kidney transplantation during hospitalization * incomplete clinical information * Serum creatinine always ≤ 40 μmol/L during hospitalization

Locations (1)

The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital

Jinan, Shandong, China

Outcomes

Primary Outcomes

AKI

During the patient's hospitalization, acute kidney injury occurred after the use of Iodinated contrast media

Time frame: Completed through study, up to half a year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.